BIOMAT Database Logo BIOMAT Database Logo

Bacteriocin (acnecin) activity of oral Propionibacterium acnes. 1978

T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa

UI MeSH Term Description Entries
D011425 Propionibacterium acnes A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants. Corynebacterium acnes,Corynebacterium parvum
D003773 Dental Plaque A film that attaches to teeth, often causing DENTAL CARIES and GINGIVITIS. It is composed of MUCINS, secreted from salivary glands, and microorganisms. Plaque, Dental
D006131 Growth Inhibitors Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth ( Cell Growth Inhibitor,Cell Growth Inhibitors,Growth Inhibitor,Growth Inhibitor, Cell,Growth Inhibitors, Cell,Inhibitor, Cell Growth,Inhibitor, Growth,Inhibitors, Cell Growth,Inhibitors, Growth
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001430 Bacteriocins Substances elaborated by specific strains of bacteria that are lethal against other strains of the same or related species. They are protein or lipopolysaccharide-protein complexes used in taxonomy studies of bacteria. Bacteriocin,Lantibiotic,Lantibiotics

Related Publications

T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa
Haemagglutinating activity of Propionibacterium acnes isolated from the human oral cavity.
May 1980, The Bulletin of Tokyo Dental College,
T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa
Adjuvant activity of Propionibacterium acnes isolated from the human oral cavity.
January 1977, Archives of oral biology,
T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa
Does oral isotretinoin prevent Propionibacterium acnes resistance?
January 1997, Dermatology (Basel, Switzerland),
T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa
Propionibacterium acnes.
July 1988, BMJ (Clinical research ed.),
T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa
Propionibacterium acnes.
March 2006, Letters in applied microbiology,
T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa
Antibacterial activity of retinaldehyde against Propionibacterium acnes.
January 1999, Dermatology (Basel, Switzerland),
T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa
Culture and biological activity of Propionibacterium acnes.
January 1997, Infection,
T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa
Corrigendum: Proposal to reclassify Propionibacterium acnes type I as Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes type II as Propionibacterium acnes subsp. defendens subsp. nov.
November 2017, International journal of systematic and evolutionary microbiology,
T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa
Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
October 2006, Journal of drugs in dermatology : JDD,
T Nakamura, and S Fujimura, and N Obata, and N Yamazaki, and N Kanagawa
Discovery and Characterization of a Novel Bacteriocin HA2-5 that Strongly Inhibits Propionibacterium acnes.
August 2023, Journal of agricultural and food chemistry,
Copied contents to your clipboard!